Computed tomography-guided bronchoalveolar lavage in idiopathic pulmonary fibrosis

Thorax

Volumn 51, Issue 8, 1996, Pages 841-845

  Agusti, C ^a   Xaubet, A ^a,b   Luburich, P ^a   Ayuso, M C ^a   Roca, J ^a   Rodriguez Roisin, R ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

alveolitis; high resolution CT scanning; interstitial lung fibrosis

Indexed keywords

ADULT; ARTICLE; CELL POPULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LEUKOCYTE DIFFERENTIAL COUNT; LUNG FIBROSIS; LUNG LAVAGE; LUNG LOBE; MALE; PRIORITY JOURNAL;

EID: 0029787451     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.8.841     Document Type: Article

References (34)

1. Crystal RG, Fulmer JD, Roberts WC, Moss ML, Line BR, Reynolds HY. Idiopathic pulmonary fibrosis: clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med 1976; 85:769-88.
2. Keogh BA, Crystal RG. Alveolitis: the key to the interstitial lung disorders. Thorax 1982;37:1-10.
3. Carrington CB, Gaensler EA, Coutu RE, Fitzgerald MX, Gupta RG. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978; 298:801-11.
4. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980;35:171-80.
5. Hunninghake GW, Gadek JE, Kawanami O, Ferrans VJ, Crystal RG. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol 1979;97:149-206.
6. Davis GS, Brody AR, Craighead JE. Analysis of airspace and interstitial mononuclear cell populations in human diffuse interstitial lung disease. Am Rev Respir Dis 1978;118:7-15.
7. Haslam PL. Bronchoalveolar lavage in interstitial lung disease. Semin Respir Med 1984;6:55-70.
8. Haslam PL. Cryptogenic fibrosing alveolitis: pathogenetic mechanisms and therapeutic approaches. Eur Respir J 1990;3:355-7.
9. Haslam PL, Turton CWG, Lukoszek A, Collins JV, Salsbury AJ, Turner-Warwick M. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy, Thorax 1980;35:328-39.
10. Rudd RM, Haslam PL, Turner-Warwick M. Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis 1981;124:1-8.
11. Peterson MW, Monick M, Hunninghake GW. Prognostic role of eosinophils in pulmonary fibrosis. Chest 1987; 92:51-6.
12. Watters LC, Schwartz MI, Cherniack RM, Waldron JA, Dunn TL, Stanford RE, et al. Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis 1987; 135:696-704.
13. Schwartz DA, Van Fossen DS, Davis CS, Helmers RA, Dayton CS, Burmeister LF, et al. Determinants of progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994;149:444-9.
14. Schwartz DA, Helmers RA, Dayton CS, Merchant RK, Hunninghake GW. Determinants of bronchoalveolar lavage cellularity in idiopathic pulmonary fibrosis. J Appl Physiol 1991;71:1688-93.
15. Garcia JGN, Wolven RG, Garcia PL, Keogh BA. Assessment of interlobar variation of bronchoalveolar lavage cellular differentials in interstitial lung diseases. Am Rev Respir Dis 1986;133:444-9.
16. Schwartz DA, Helmers RA, Galvin JR, Van Fossen DS, Frees KL, Dayton CS, et al. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994;149:450-4.
17. Wells AU, Hansell DM, Rubens MB, Cullinan P, Black CM, du Bois RM. The predictive value of appearances on thinsection computed tomography in fibrosing alveolitis. Am Rev Respir Dis 1993;148:1076-82.
18. Müller NL, Miller RR, Webb WR, Evans KG, Ostrow DN. Fibrosing alveolitis: CT-pathologic correlation. Radiology 1986;160:585-8.
19. Müller NL, Stables CA, Miller RR, Vedal S, Thurbeck WM, Ostrow DN. Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. Radiology 1987; 165:731-4.
20. Nishimura K, Litaichi M, Izumi T, Nagai S, Kanaoka M, Itoh H. Usual interstitial pneumonia: histologic correlation with high resolution CT. Radiology 1992;182:337-42.
21. Agusti C, Xaubet A, Agusti AGN, Roca J, Ramirez J, Rodriguez-Roisin R. Clinical and functional assessment of patients with idiopathic pulmonary fibrosis: results of a 3 year follow-up. Eur Respir J 1994;7:643-50.
22. Agusti C, Xaubet A, Roca J, Agusti AGN, Rodriguez-Roisin R. Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year followup. Thorax 1992;47:1035-40.
23. Hansell DM, Kerr IH. The role of high resolution computed tomography in the diagnosis of interstitial lung disease. Thorax 1991;46:77-84.
24. Leung AN, Miller RR, Müller NL. Parenchymal opacification in chronic infiltrative lung diseases: CT-pathologic correlation. Radiology 1993;188:209-14.
25. Roca J, Sanchis J, Agusti-Vidal A, Segarra F, Navajas D, Rodriguez-Roisin R, et al. Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir 1986;22:217-24.
26. Roca J, Rodriguez-Roisin R, Cobo E, Burgos F, Pérez J, Clausen JL. Single-breath carbon monoxide diffusing capacity (DLCO) prediction equations from a Mediterranean population. Am Rev Respir Dis 1990;140:1026-32.
27. Xaubet A, Rodriguez-Roisin R, Bombi JA, Marin A, Roca J, Agusti Vidai A. Correlation of bronchoalveolar lavage and clinical and functional findings in asbestosis. Am Rev Respir Dis 1986;133:848-54.
28. Xaubet A, Agusti C, Roca J, Picado C, Rodriguez-Roisin R. BAL lymphocyte activation antigens and diffusing capacity are related in mild to moderate pulmonary sarcoidosis. Eur Respir J 1993;6:715-8.
29. Peterson MW, Nugent KM, Jolles H, Monick M, Hunninghake GW. Uniformity of bronchoalveolar lavage in patients with pulmonary sarcoidosis. Am Rev Respir Dis 1988; 137:79-84.
30. Scott Miller K, Smith EA, Kinsella M, Schabel SI, Silver RM. Lung disease associated with progressive systemic sclerosis. Am Rev Respir Dis 1990;141:301-6.
31. Daniele RP, Dantzker DR, Davis GS, Hunninghake GW, King TE Jr, Metzger WJ, et al. Clinical role of bronchoalveolar lavage in adults with pulmonary disease. Am Rev Respir Dis 1990;142:481-6.
32. Turner-Warwick M, Haslam PL. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis 1987;135:26-34.
33. Wells AU, Hansell DM, Rubens MB, Cullinan P, Haslam PL, Black CM, et al. Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance. Am J Respir Crit Care Med 1994;150:462-8.
34. Wells AU, Hansell DM, Corrin B, Harrison NK, Goldstraw P, du Bois RM. High resolution computed tomography as a predictor of lung histology in systemic sclerosis. Thorax 1992;47:508-12.